摘要
背景:随着全球老年人口的增加,现代社会必须找到减少老龄化过程后果的策略;从而降低年龄相关性神经退行性疾病的发病率。已经指出氧化应激和最近的炎症是脑衰老的主要原因。因此,抗氧化剂和抗炎分子(如多酚)的消耗或给药是推荐用于预防脑老化和几种脑老化相关疾病的有益策略。 方法和结果:几项研究表明,饮食多酚的长期食用可防止神经退行性疾病的发展。这些有益的作用部分归因于它们的抗氧化和抗炎特性,以及它们在调节涉及几种神经退行性疾病(例如,表观遗传因子,淀粉样蛋白沉积,胆碱酯酶抑制,自体吞噬和神经营养的病理生理学的过程中的积极作用因素等)。总之,这些分子为研究新的神经保护策略打开了大门。这篇综述总结了多酚在衰老过程中如何对大脑健康产生积极作用的最新发现,强调了衰老过程中最常影响大脑的疾病:帕金森病(PD),阿尔茨海默病(AD),痴呆和抑郁症。此外,在内部解决多酚作为可能的调解人对大脑健康的积极影响的后生效应,以及未来在这个主题的研究挑战 结论:简单地说,这篇综述提供了关于多酚对最常见的脑部老化相关疾病以及健康大脑老化的正面影响的最新知识的报告。
关键词: 多酚,老化,抗氧化,抗炎,表观遗传,神经退行性疾病
Current Medicinal Chemistry
Title:Effects of Resveratrol and Other Polyphenols on the Most Common Brain Age-Related Diseases
Volume: 24 Issue: 38
关键词: 多酚,老化,抗氧化,抗炎,表观遗传,神经退行性疾病
摘要: Background: With global increase in elderly population, modern societies must find strategies to reduce the consequences of aging process; thereby decreasing the incidence of age-related neurodegenerative diseases. Oxidative stress and recently inflammation, have been pointed out as the leading causes of brain aging. Thereby, the consumption or administration of antioxidant and anti-inflammatory molecules, such as polyphenols, is a beneficial strategy recommended for preventing brain aging and several brain age-related diseases.
Methods and Results: Several studies suggest that long term consumption of dietary polyphenols offers protection against development of neurodegenerative diseases. These beneficial effects are in part due to their antioxidant and anti-inflammatory properties, together with their positive role in the modulation of processes involved in the physiopathology of several neurodegenerative diseases (e.g., epigenetic factors, amyloid deposition, cholinesterase inhibition, autophagy, and neurotrophic factors, among others). Altogether, these molecules open the door to the research of new neuroprotective strategies. This review summarizes the latest discoveries in how polyphenols can exert positive effects on brain health in aging, emphasizing those effects on the diseases that most commonly affect the brain during aging: Parkinson's Disease (PD), Alzheimer's disease (AD), dementia and depression. Moreover, within are addressed the epigenetic effects of polyphenols as possible mediators in their positive effects on brain health, and the future challenges of research in this topic
Conclusion: In brief, this review presents a report of state-of the art knowledge regarding the positive influences of polyphenols on the most common brain age-related diseases as well as in healthy brain aging.
Export Options
About this article
Cite this article as:
Effects of Resveratrol and Other Polyphenols on the Most Common Brain Age-Related Diseases, Current Medicinal Chemistry 2017; 24 (38) . https://dx.doi.org/10.2174/0929867324666170724102743
DOI https://dx.doi.org/10.2174/0929867324666170724102743 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimers Disease, Depression, and Parkinsons Disease
Current Bioactive Compounds Differential Expression of Ribosomal Genes in Brain and Blood of Alzheimer’s Disease Patients
Current Alzheimer Research Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia
Current Psychiatry Reviews Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
Current Alzheimer Research Intracerebrally Applied Botulinum Neurotoxin in Experimental Neuroscience
Current Pharmaceutical Biotechnology COVID-19-associated Coagulopathy and Thromboembolism: Determination of Their Patterns and Risk Factors as Predictors of Mortality Among Severe COVID-19 Patients
Current Vascular Pharmacology Synthesis, Antioxidant and Anti-inflammatoy Effects of Antioxidant Acid Amides with GABA and N-Acyl-pyrrolidin-2-ones
Current Chemical Biology Subject Index to Volume 10
Current Pharmaceutical Design The Molecular Basis of Memantine Action in Alzheimers Disease and Other Neurologic Disorders: Low-affinity, Uncompetitive Antagonism
Current Alzheimer Research Ruthenium as an Effective Nitric Oxide Scavenger
Current Topics in Medicinal Chemistry The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Anti-Cancer Agents in Medicinal Chemistry Late Life Depression: A Diagnostic and Pharmacological Review
Current Psychopharmacology Vascular Effects of Ambient Pollutant Particles and Metals
Current Vascular Pharmacology Protection Mechanisms Against Aβ42 Aggregation
Current Alzheimer Research Complex Polyamines: Unique Prion Disaggregating Compounds
CNS & Neurological Disorders - Drug Targets Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
Current Medicinal Chemistry Cannabinoids and Myocardial Ischemia: Novel insights, Updated Mechanisms, and Implications for Myocardial Infarction
Current Medicinal Chemistry FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects
Current Radiopharmaceuticals Mechanisms of Mononuclear Phagocyte Recruitment in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Buccal Cell Cytokeratin 14 Identifies Mild Cognitive Impairment and Alzheimer’ s Disease in the AIBL Study of Aging
Current Alzheimer Research